Regeneron Pharmaceuticals
REGN
#232
Rank
C$136.94 B
Marketcap
C$1,324
Share price
0.13%
Change (1 day)
34.14%
Change (1 year)

EPS for Regeneron Pharmaceuticals (REGN)

EPS in 2026 (TTM): C$66.16

According to Regeneron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is C$67.33. In 2025 the company made an earnings per share (EPS) of C$61.80 an increase over its 2024 EPS that were of C$58.59.

EPS history for Regeneron Pharmaceuticals from 2010 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$66.167.06%
2025C$61.805.48%
2024C$58.5910.34%
2023C$53.10-8.56%
2022C$58.08-47%
2021C$109.57133.36%
2020C$46.9569.13%
2019C$27.76-14.44%
2018C$32.45100.71%
2017C$16.1731.78%
2016C$12.2738.96%
2015C$8.8372.55%
2014C$5.12-17.55%
2013C$6.21-44.98%
2012C$11.28
2010C-$1.82

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$9.57-85.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$7.52-88.83%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
C$24.91-63.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$2.84-95.78%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
C$3.38-94.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
C$28.39-57.83%๐Ÿ‡บ๐Ÿ‡ธ USA